Companies often treat Japan as an afterthought. But as the U.S. market shifts to value-based care and hospitals consolidate vendors, and as the EU implements the stricter MDR, the country may look more attractive.
How big is the orthopaedic market and its subsegments? What market forces should companies consider in 2019? What are the orthopaedic technology buzzwords going around today?
The Japan-based manufacturer of joint replacement devices plans to grow its U.S. business through acquisition of Renovis' primary assets, which include hip and knee joint reconstruction, spinal and trauma devices.
Dr. Martin Roche says, "The surgeon still wants to operate, but if this technology makes procedures more consistent, efficient and generates improved outcomes, patients will request it and surgeons will use the data to develop new surgical procedures and personalized implants."
